{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"}],"units":"Participants"}],"description":"An AE is any untoward medical occurrence in a study participant administered a pharmaceutical product that does not necessarily have to have a causal relationship with this treatment. An AE can therefore be any unfavorable and unintended sign, symptom, or disease temporally associated with the use of a medicinal product, whether or not related to the medicinal product.","groups":[{"description":"Participants received a single 35 mg dose of sotatercept by SC injection on Day 1, Day 43, and Day 85.","id":"OG000","title":"Sotatercept"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"All participants who received at least one dose of study treatment.","reportingStatus":"POSTED","timeFrame":"Up to approximately 7 months","title":"Number of Participants Who Experienced One or More Adverse Events (AEs)","type":"SECONDARY","unitOfMeasure":"Participants"}